48
Participants
Start Date
December 31, 2006
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2010
Everolimus
"RAD001 will be supplied by Novartis as tablets in 3 different dosage strengths, 2.5, 5 and 10 mg. All proposed dose levels in this study can be given as a combination of these dose strengths.~Daily doses of 2.5, 5, 7.5 and 10 mg of RAD001 will be given alongside the standard 21-day cycle of pemetrexed."
Pemetrexed
Pemetrexed was supplied to the sites in 500 mg/m2 was administered on Day 1 of each cycle as a 10-minute continuous i.v. infusion in 100mL normal saline
Novartis Investigative Site, Camperdown
Novartis Investigative Site, Leuven
Novartis Investigative Site, Melbourne
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Cologne
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY